Also from this source

You just read:

PROCLAIM(SM) Patient Registry Data Demonstrates Safety and Efficacy of Proleukin® (aldesleukin) When Sequenced with Immune Checkpoint Inhibitors in Metastatic Melanoma

News provided by

Prometheus Laboratories, Inc.

May 28, 2015, 08:00 ET